GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » Research & Development

Hangzhou Minsheng Healthcare Co (SZSE:301507) Research & Development : ¥29.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hangzhou Minsheng Healthcare Co's Research & Development for the three months ended in Mar. 2024 was ¥10.2 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥29.5 Mil.


Hangzhou Minsheng Healthcare Co Research & Development Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co Research & Development Chart

Hangzhou Minsheng Healthcare Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 17.04 17.30 24.07 27.17 29.56

Hangzhou Minsheng Healthcare Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.33 5.60 6.97 6.66 10.24

Hangzhou Minsheng Healthcare Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥29.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Minsheng Healthcare Co  (SZSE:301507) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Hangzhou Minsheng Healthcare Co Research & Development Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Minsheng Healthcare Co (SZSE:301507) Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100
Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co (SZSE:301507) Headlines

No Headlines